XAGE (Longevity Health Holdings) Additional Paid-In Capital : $66.57 Mil(As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Longevity Health Holdings Additional Paid-In Capital?

Longevity Health Holdings's quarterly additional paid-in capital increased from Sep. 2024 ($63.89 Mil) to Dec. 2024 ($64.16 Mil) and increased from Dec. 2024 ($64.16 Mil) to Mar. 2025 ($66.57 Mil).

Longevity Health Holdings's annual additional paid-in capital increased from Dec. 2022 ($4.59 Mil) to Dec. 2023 ($83.25 Mil) but then declined from Dec. 2023 ($83.25 Mil) to Dec. 2024 ($64.16 Mil).

Longevity Health Holdings Additional Paid-In Capital Historical Data

The historical data trend for Longevity Health Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Health Holdings Additional Paid-In Capital Chart

Longevity Health Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

3.16

4.59

83.25

64.16

Longevity Health Holdings Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial								60.38	63.71	63.89	64.16	66.57

Longevity Health Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Longevity Health Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Longevity Health Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Health Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Longevity Health Holdings Inc (NAS:XAGE) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

2403 Sidney Street, Suite 300, Pittsburgh, PA, USA, 15203

Website

https://www.carmellcorp.com

Longevity Health Holdings Inc is a United States based bio-aesthetics company focused on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company has two cosmetic product lines, Carmell Secretome and Elevai Exosomes, that support skin and hair health.

Executives

Richard A Upton	director	12 MIDDLE STREET, AMHERST NH 03031
Kathryn Gregory	director	305 THAYER POND ROAD, WILTON CT 06897
Patrick A Sturgeon	officer: CFO and Secretary	600 LEXINGTON AVENUE 33 FLOOR, NEW YORK NY 10022
David W Anderson	director	519 LYNMERE ROAD, BRYN MAWR PA 19010
Rajiv Shukla	director, 10 percent owner, officer: Chief Executive Officer	EMERALD VIEW SUITE 400, 2054 VISTA PARKWAY, WEST PALM BEACH FL 33411
Randolph W Hubbell	director, officer: President and CEO	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
William R Newlin	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Steven Bariahtaris	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Jaime Garza	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Janet Vargo	officer: VP Clinical Services	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Donna Godward	officer: Chief Quality Officer	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
James C Hart	officer: Chief Medical Officer	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
William Woodward	director	ANTHEM VENTURE PARTNERS, 225 ARIZONA AVENUE, SUITE 200, SANTA MONICA CA 90401
Darlene T Deremer	director	200 CENTRAL AVENUE, SUITE 1850, ST. PETERSBURG FL 33701
Ahac Sponsor Iii Llc	10 percent owner	1177 AVENUE OF THE AMERICAS, 5TH FLOOR, NEW YORK NY 10036